These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 24984271

  • 1. Angiogenic growth factor expression in benign and malignant vascular tumours.
    Young RJ, Fernando M, Hughes D, Brown NJ, Woll PJ.
    Exp Mol Pathol; 2014 Aug; 97(1):148-53. PubMed ID: 24984271
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
    Kaga T, Kawano H, Sakaguchi M, Nakazawa T, Taniyama Y, Morishita R.
    Vascul Pharmacol; 2012 Aug 19; 57(1):3-9. PubMed ID: 22361334
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
    Konstantinovsky S, Nielsen S, Vyberg M, Kvalheim G, Nesland JM, Reich R, Davidson B.
    Breast Cancer Res Treat; 2005 Nov 19; 94(1):71-80. PubMed ID: 16142438
    [Abstract] [Full Text] [Related]

  • 8. Vascular-targeted agents for the treatment of angiosarcoma.
    Young RJ, Woll PJ, Staton CA, Reed MW, Brown NJ.
    Cancer Chemother Pharmacol; 2014 Feb 19; 73(2):259-70. PubMed ID: 24253175
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.
    Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM.
    Clin Cancer Res; 1996 Oct 19; 2(10):1679-84. PubMed ID: 9816116
    [Abstract] [Full Text] [Related]

  • 17. Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes.
    Kodama A, Sakai H, Matsuura S, Murakami M, Murai A, Mori T, Maruo K, Kimura T, Masegi T, Yanai T.
    BMC Cancer; 2009 Oct 14; 9():363. PubMed ID: 19825192
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B.
    Am J Pathol; 1998 Jun 14; 152(6):1433-43. PubMed ID: 9626048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.